• 1
    Feldman EC, Nelson RW. Pheochromocytoma and multiple endocrine neoplasia. In: FeldmanEC, NelsonRW, eds. Canine and Feline Endocrinology and Reproduction, 3rd ed. St Louis, MI: Saunders Elsevier; 2004:440463.
  • 2
    Galac S, Reusch CE, Kooistra HS, et al. Adrenals. In: RijnberkA, KooistraHS, eds. Clinical Endocrinology of Dogs and Cats, 2nd ed. Hannover, Germany: Schlütersche Verlagsgesellschaft mbH&Co KG; 2010:93154.
  • 3
    Herrera M, Nelson RW. Pheochromocytoma. In: EttingerSJ, FeldmanEC, eds. Textbook of Veterinary Internal Medicine. Diseases of the Dog and the Cat, 7th ed. St Louis, MO: Saunders Elsevier; 2010:18651871.
  • 4
    Cryer PE. Diseases of the sympathochromaffin system. In: FeligP, FrohmanLA, eds. Endocrinology & Metabolism, 4th ed. New York, NY: McGraw-Hill Inc, Medical Publishing Division; 2001:525551.
  • 5
    Unger N, Pit C, Schmidt IL, et al. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 2006;154:409417.
  • 6
    Lee JA, Zarnegar R, Shen WT, et al. Adrenal incidentaloma, borderline elevations of urine or plasma metanephrine levels, and the “subclinical” pheochromocytoma. Arch Surg 2007;142:870874.
  • 7
    Harding JL, Yeh MW, Robinson BG, et al. Potential pitfalls in the diagnosis of phaeochromocytoma. Med J Aust 2005;182:637639.
  • 8
    Kook PH, Boretti FS, Hersberger M, et al. Urinary catecholamine and metanephrine to creatinine ratios in healthy dogs at home and in a hospital environment and in 2 dogs with pheochromocytoma. J Vet Intern Med 2007;21:388393.
  • 9
    Kook PH, Grest P, Quante S, et al. Urinary catecholamine and metanephrine to creatinine ratios in dogs with a phaeochromocytoma. Vet Rec 2010;166:169174.
  • 10
    Rosas AL, Kasperlik-Zaluska AA, Papierska L, et al. Pheochromocytoma crisis induced by glucocorticoids: A report of four cases and review of the literature. Eur J Endocrinol 2008;158:423429.
  • 11
    Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002;63:506512.
  • 12
    Besso JG, Penninck DG, Gliatto JM. Retrospective ultrasonographic evaluation of adrenal lesions in 26 dogs. Vet Radiol Ultrasound 1997;38:448455.
  • 13
    Von Dehn BJ, Nelson RW, Feldman ES, et al. Pheochromocytoma and hyperadrenocorticism in dogs: Six cases (1982–1992). J Am Vet Med Assoc 1995;207:322324.
  • 14
    Thuroczy J, Van Sluijs FJ, Kooistra HS, et al. Multiple endocrine neoplasias in a dog: Corticotrophic tumour, bilateral adrenocortical tumours, and pheochromocytoma. Vet Quart 1998;20:5661.
  • 15
    Guller U, Turek J, Eubanks S, et al. Detecting pheochromocytoma. Defining the most sensitive test. Ann Surg 2006;243:102107.
  • 16
    Eisenhofer G, Siegert G, Kotzerke J, et al. Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas. Horm Metab Res 2008;40:329337.
  • 17
    Lenders JW, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet 2005;366:665675.
  • 18
    Wurtman RJ. Control of epinephrine synthesis in the adrenal medulla by the adrenal cortex: Hormonal specificity and dose-response characteristics. Endocrinology 1966;79:608614.
  • 19
    Goodman R, Edgar D, Thoenen H, et al. Glucocorticoid induction of tyrosine hydroxylase in a continuous cell line of rat pheochromocytoma. J Cell Biol 1978;78:R1R7.
  • 20
    Tischler AS, Perlman RL, Morse GM, et al. Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures. J Neurochem 1983;40:364370.
  • 21
    Critchley JA, Henderson CG, Moffat LE. Proceedings: The release of catecholamines from perfused canine adrenal glands by corticosteroids. J Physiol 1976;254:3031.
  • 22
    Grossman A, Pacak K, Sawka A, et al. Biochemical diagnosis and localization of pheochromocytoma. Can we reach a consensus? Ann NY Acad Sci 2006;1073:332347.